However, the incidence of negative PTEN expression using immunohistochemistry of breast tumors was reported to be as high as 30% 1, which suggests that somatic mutations in PTEN are only a small proportion of breast tumors with PTEN loss-of-function. The gene discussed is PTEN; the disease is breast neoplasm.